GSK raised its 2024 full-year guidance thanks to rising demand for its oncology portfolio and long-acting HIV medications. Read more on GSK stock here.

GSK has expanded its voluntary licensing agreement with the United Nations-backed Medicines Patent Pool (MPP) for ...

(RTTNews) - GSK plc (GSK, GSK.L), on Thursday, said it has agreed with Chongqing Zhifei Biological Products Ltd. to revise the terms on which Zhifei will commercialize GSK's shingles vaccine ...

GSK, Zhifei Revise And Extend Strategic Vaccine Collaboration In China December 05, 2024 — 02:32 am EST Written by RTTNews.com for RTTNews -> ...

Recent developments illustrate dynamic shifts in the healthcare sector. Trump's spending bill is anticipated to challenge ...

GSK has shifted towards a global marketing model influenced by a Netflix-style approach that aims to match content to the person receiving it. Richard Staines heard about this new strategy at the ...

Strategic collaboration with GSK expanded to accelerate clinical development of alpibectir for the treatment of tuberculosisGSK to participate in ...

Wave, GSK enter strategic collaboration that could be worth up to $3.3 billion in milestone payments. Published: Dec. 13, 2022 at 11:27 a.m. ET. Share. Resize.

BANGKOK, Dec. 17, 2024 /PRNewswire/ -- Dr. Gur Levy, Respiratory Medical Expert at GSK, said, "We have been pioneering efforts for decades to develop new therapeutic alternatives that set the ...

Strategic collaboration with GSK expanded to accelerate ... We believe that working in partnership on priorities that are aligned to and support global health challenges gives both companies ...

GSK hosted the third annual RespiVerse Meeting on December 13 and 14 in Bangkok, Thailand. The event brought together renowned international speakers and healthcare professionals from 17 countries to ...